Post Profile

New Gene-Therapy Treatments Will Carry Whopping Price Tags

Kymriah, approved recently by the F.D.A., with a $475,000 price tag, is first of a coming wave of treatments whose expected prices have alarmed economists, scientists and insurers.
read more


Related Posts

The Other Innovation Of This $475,000 Cancer Drug: You Only Pay If You Get Better

Business & Finance : Fast Company

Novartis defends the eye-popping price of its pioneering gene therapy with arguments about its $1 billion expenditure—and novel “value-based” pricing. After the FDA approved Kymriah—a futuristic gene therapy meant to treat children ...

A $475,000 price tag for a new cancer drug

News : The Raw Story

Forget McGregor-Mayweather. The biotech world has been waiting for months to hear about Novartis’ pricing decision for Kymriah, its just-approved CAR-T therapy for cancer. That interest turned into anxiety days earlier when Gilead a...

Pioneering Cancer Gene Therapy Gets Greenlight — And $475,000 Price Tag

Health : The Checkup

The country’s first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced. Switzerland-...

Revolutionary gene therapy approved for leukemia — at $475,000 price tag

News : USAToday: News

FDA approved the therapy, called Kymriah, in children and young adults with acute lymphoblastic leukemia whose disease has come back in spite of previous treatments.        

Kymriah, the First Gene Therapy, Arrives—With a $475,000 Price Tag

News : Trending Now

The Food and Drug Administration's approval of Kymriah was met with excitement for its potential—as well as concerns about the $475,000 cost of this breakthrough gene therapy treatment for a life...


Copyright © 2016 Regator, LLC